These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 24119739)

  • 1. [Clinical features of antiviral therapy in 12 patients with hepatitis C virus-related cirrhosis after splenectomy].
    Ma LN; He ZM; Hua W; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):594-8. PubMed ID: 24119739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of individualized therapeutic programs on chronic hepatitis C and the influential factors of virological response].
    Cheng ML; Wang J; Zeng AP; Liu XF
    Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):751-4. PubMed ID: 23290969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peg-IFNa-2a/RBV antiviral efficacy in cirrhotic hepatitis C patients after splenectomy or partial splenic embolization].
    Xie YM; Li B; Ma L; Pan L; Wei X; Peng XJ; Hao CQ; Zhang Y; Bai XF; Kang WZ; Jia ZS
    Zhonghua Gan Zang Bing Za Zhi; 2012 Feb; 20(2):112-5. PubMed ID: 22464782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of low-dose interferon therapy for treating chronic hepatitis C patients who cannot tolerate standard treatment].
    Cao ZH; Liu YL; Zheng YH; Ji SD; Wang JL; Liao JH; Zhang CY; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jan; 20(1):20-4. PubMed ID: 22464701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
    Mancuso ME; Rumi MG; Aghemo A; Santagostino E; Puoti M; Coppola A; Colombo M; Mannucci PM
    J Thromb Haemost; 2009 Dec; 7(12):1997-2005. PubMed ID: 19799716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.
    Saito T; Sugimoto M; Igarashi K; Saito K; Shao L; Katsumi T; Tomita K; Sato C; Okumoto K; Nishise Y; Watanabe H; Tomita M; Ueno Y; Soga T
    Metabolism; 2013 Nov; 62(11):1577-86. PubMed ID: 23953890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Life quality analysis of hepatitis C patients with liver cirrhosis undergoing antiviral therapy following splenectomy].
    Ji G; Guo Y; Chen L; Zhang Y; He Y; Ma L; Wang Y; Ma Z; Cheng C; Jia Z
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):195-9. PubMed ID: 24824121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis.
    Inagaki Y; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Ogura S; Yamamoto N; Takei Y; Ito M; Mizuno S; Usui M; Sakurai H; Isaji S
    Mol Med Rep; 2014 Feb; 9(2):487-92. PubMed ID: 24336960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies.
    Grotzinger KM; Younossi ZM; Giannini EG; Chen PJ; Rendas-Baum R; Theodore D
    Health Qual Life Outcomes; 2016 Mar; 14():49. PubMed ID: 27004952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis.
    Ji F; Zhang S; Huang N; Deng H; Li Z
    Braz J Infect Dis; 2013; 17(5):601-5. PubMed ID: 23830054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie.
    Poynard T; Moussalli J; Ratziu V; Thevenot T; Regimbeau C; Opolon P; Horsmans Y; Brenard R; Closon M; Fevery J; Hautekeete M
    Acta Gastroenterol Belg; 1998; 61(4):431-7. PubMed ID: 9923094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic indices improve with eradication of HCV in patients with cirrhosis and predict decompensation.
    Karagozian R; Grace ND; Qamar AA
    Acta Gastroenterol Belg; 2014 Dec; 77(4):425-32. PubMed ID: 25682633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, Child's status and institution of specific treatment for hepatitis C with success.
    Kedia S; Goyal R; Mangla V; Kumar A; S S; Das P; Pal S; Sahni P; Acharya SK
    Ann Hepatol; 2012; 11(6):921-9. PubMed ID: 23109457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High sustained virological response to optimized therapy for refractory chronic hepatitis C treatment-na(i)ve patients: a multicenter randomized study].
    Chen X; Shang J; Yang R; Xie Q; Gao Z; Xu X; Dou X; Gong G; Chen G; Li J; Chen H; Zhang D; Feng Y; Niu J; Hou J; You H; Wu Y; Zhao P; Rao H; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):412-7. PubMed ID: 26236925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of simultaneous splenectomy in liver transplant recipients with hepatitis C virus.
    Morimoto H; Ishiyama K; Ishifuro M; Ohira M; Ide K; Tanaka Y; Tahara H; Teraoka Y; Yamashita M; Abe T; Hashimoto S; Hirata F; Tanimine N; Saeki Y; Shimizu S; Sakai H; Yano T; Tashiro H; Ohdan H
    Transplant Proc; 2014 Apr; 46(3):770-3. PubMed ID: 24767345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy for thrombocytopenia in patients with hepatitis C cirrhosis.
    Davern TJ
    J Clin Gastroenterol; 2008 Aug; 42(7):863-4. PubMed ID: 18469723
    [No Abstract]   [Full Text] [Related]  

  • 19. Regression of liver fibrosis in patients treated by interferon.
    Omata M
    Intern Med; 2004 Oct; 43(10):887-8. PubMed ID: 15575231
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral treatment for hepatitis C cirrhosis: is the effort justified?
    Black M; Thomas R
    Ann Intern Med; 2008 Sep; 149(6):427-8. PubMed ID: 18794563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.